MHRA approves donidalorsen (Dawnzera) for the treatment of familial chylomicronemia syndrome
seen at 15:18, 7 May in News and communications.MHRA approves donidalorsen (Dawnzera) for the treatment of familial chylomicronemia syndrome
seen at 15:18, 7 May in News and communications.